Evercore ISI initiated coverage on BioMarin Pharmaceutical with a new price target
$BMRN
Biotechnology: Pharmaceutical Preparations
Health Care
Evercore ISI initiated coverage of BioMarin Pharmaceutical with a rating of Outperform and set a new price target of $113.00